En esta página
JANX Janux Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$16,93
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$12,42mínimo 52 semanas
$35,34máximo 52 semanas
Capitalización Bursátil (MRQ)
$1.03B
P/E (TTM)
-10.3
BPA (TTM)
$-1.64
Ingresos (TTM)
$24M
tus insignias
Rango 52S
$12–$35
Calificación del Analista
BUY
Precio Objetivo
$36
P/E
-10.3
ROE
-10.7%
Margen de Beneficio Neto
-427.5%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
JANX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$16.93
Capitalización Bursátil (MRQ)
$1.03B
P/E (TTM)
-10.3
BPA (TTM)
$-1.64
Ingresos (TTM)
$24M
ROE (TTM)
-10.7%
Rango 52S
$12–$35
JANX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$10M2020-12-31 → 2025-12-31
BPA$-1.832021-12-31 → 2025-12-31
Flujo de caja libre$-83M2021-12-31 → 2025-12-31
Margen neto-427.5%2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | JANX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -10.3promedio 5A ≈-16.1 | ≈-16.1 | · | · | |
| P/S (TTM) | 43.1promedio 5A ≈146.2 | ≈146.2 | 12.6 | Sobrevalorado | |
| P/C (MRQ) | 1.1promedio 5A ≈1.9 | ≈1.9 | 4.2 | Infravalorado | |
| Precio / FCF (TTM) | -24.7promedio 5A ≈-29.2 | ≈-29.2 | · | · | |
| Precio / Flujo de Caja (TTM) | -25.1promedio 5A ≈-30.6 | ≈-30.6 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.1promedio 5A ≈1.9 | ≈1.9 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | JANX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -598.1%promedio 5A ≈-1019.5% | ≈-1019.5% | -329.2% | En línea | |
| EBITDA Margin (Margen EBITDA) | -1576.7%promedio 5A ≈-1019.5% | ≈-1019.5% | -329.2% | En línea | |
| Margen de Beneficio Neto (TTM) | -427.5%promedio 5A ≈-827.9% | ≈-827.9% | -270.7% | De primer nivel | |
| ROA (TTM) | -10.1%promedio 5A ≈-13.9% | ≈-13.9% | -29.5% | De primer nivel | |
| ROE (TTM) | -10.7%promedio 5A ≈-13.0% | ≈-13.0% | -18.5% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | JANX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 16.3promedio 5A ≈34.9 | ≈34.9 | 10.4 | Liquidez sólida | |
| Ratio Rápido (MRQ) | 16.1promedio 5A ≈34.6 | ≈34.6 | 2.5 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | JANX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -5.5%promedio 5A ≈39.0% | ≈39.0% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 5.1% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | JANX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.3 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$88.5K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
14.8%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 11, 2026 | $-0.35 | $-0.39 | 10.7% |
| 31 de marzo de 2026 | May 12, 2026 | $-0.39 | $-0.54 | 27.4% |
| 31 de diciembre de 2025 | $-0.51 | $-0.66 | 22.4% | |
| 30 de septiembre de 2025 | $-0.39 | $-0.63 | 38.1% | |
| 30 de junio de 2025 | $-0.55 | $-0.48 | -15.5% | |
| 31 de marzo de 2025 | $-0.38 | $-0.40 | 5.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $10M | $11M | $8M | $9M | $4M | $0 | |
| R&D Expense | $126M | $68M | $55M | $53M | $26M | $3M | |
| SG&A Expense | $42M | $41M | $26M | $22M | $10M | $2M | |
| Operating Income | $-158M | $-99M | $-73M | $-67M | $-33M | $-5M | |
| Other Non-op | $44M | $30M | $15M | $4M | $257.0K | $-2M | |
| Income Tax | $0 | $0 | $0 | · | · | · | |
| Net Income | $-114M | $-69M | $-58M | $-63M | $-33M | $-7M | |
| EPS (Basic) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · | |
| EPS (Diluted) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · | |
| Shares (Basic) | 61,966,999 | 53,751,480 | 44,016,283 | 41,469,631 | 23,530,252 | 233,726 | |
| Shares (Diluted) | 61,966,999 | 53,751,480 | 44,016,283 | 41,469,631 | 23,530,252 | · | |
| EBITDA | $-158M | $-99M | $-73M | $-67M | $-33M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $431M | $19M | $51M | $36M | $8M | |
| Short-term Investments | $914M | $595M | $325M | $276M | $339M | $0 | |
| Receivables | $0 | · | $0 | $0 | $0 | $8M | |
| Prepaid Expense | $9M | $8M | $5M | $5M | $2M | $249.0K | |
| Current Assets | $976M | $1.03B | $349M | $332M | $377M | $16M | |
| PP&E (Net) | $4M | $5M | $7M | $7M | $1M | $155.0K | |
| PP&E (Gross) | $11M | $10M | $10M | $8M | $2M | $176.0K | |
| Accum. Depreciation | $7M | $5M | $3M | $972.0K | $131.0K | $21.0K | |
| Other Non-current Assets | $3M | $3M | $3M | $1M | $392.0K | $0 | |
| Total Assets | $1.00B | $1.06B | $380M | $364M | $380M | $16M | |
| Accounts Payable | $5M | $4M | $2M | $2M | $2M | $428.0K | |
| Accrued Liabilities | $18M | $12M | $7M | $8M | $4M | $751.0K | |
| Current Liabilities | $25M | $17M | $13M | $17M | $13M | $3M | |
| Capital Leases | $20M | $21M | $23M | $25M | $0 | $0 | |
| Total Liabilities | $45M | $39M | $36M | $43M | $13M | $9M | |
| Common Stock | $60.0K | $59.0K | $46.0K | $42.0K | $41.0K | $1.0K | |
| Retained Earnings | $-351M | $-238M | $-169M | $-110M | $-47M | $-15M | |
| AOCI | $4M | $2M | $665.0K | $-2M | $-270.0K | $0 | |
| Stockholders' Equity | $957M | $1.02B | $344M | $321M | $366M | $-15M | |
| Liabilities + Equity | $1.00B | $1.06B | $380M | $364M | $380M | $16M | |
| Shares Outstanding | 60,384,283 | 59,064,606 | 46,252,440 | 41,616,260 | 41,243,137 | 1,046,599 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $33M | $20M | $17M | $7M | $72.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-82M | $-44M | $-51M | $-43M | $-17M | $-4M | |
| CapEx | $1M | $359.0K | $2M | $6M | $1M | $0 | |
| Investing Cash Flow | $-301M | $-258M | $-41M | $58M | $-341M | $0 | |
| Financing Cash Flow | $5M | $713M | $60M | $500.0K | $387M | $12M | |
| Free Cash Flow | $-83M | $-44M | $-52M | $-49M | $-18M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | · | |
| Net Margin | -1136.2% | -651.6% | -721.2% | -732.2% | -898.3% | · | |
| EBITDA Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | · | |
| ROA | -11.0% | -9.6% | -15.7% | -17.0% | -16.5% | · | |
| ROE | -11.7% | -8.2% | -16.8% | -19.3% | -8.8% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 39.0 | 59.2 | 26.8 | 20.1 | 29.5 | · | |
| Quick Ratio | 38.7 | 58.7 | 26.4 | 19.8 | 29.3 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | · | · | 0.9 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.85 | $17.32 | $7.45 | $7.71 | $8.88 | · | |
| Revenue / Share | $0.16 | $0.20 | $0.18 | $0.21 | · | · | |
| Cash Flow / Share | $-1.33 | $-0.82 | $-1.15 | $-1.03 | · | · | |
| Cash / Share | $0.87 | $7.29 | $0.42 | $1.24 | $0.86 | · | |
| EPS (TTM) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.5% | 31.0% | -6.1% | 136.8% | · | · | |
| Revenue CAGR 3Y | 5.1% | 42.8% | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $11M | $8M | $9M | $4M | · | |
| Net Income TTM | $-114M | $-69M | $-58M | $-63M | $-33M | · | |
| Market Cap | $833M | $3.16B | $496M | $548M | $814M | · | |
| P/E | -7.5 | -41.8 | -8.1 | -8.7 | -14.2 | · | |
| P/S | 83.3 | 298.7 | 61.4 | 63.6 | 223.7 | · | |
| P/B | 0.9 | 3.1 | 1.4 | 1.7 | 2.2 | · | |
| P / Tangible Book | 0.9 | 3.1 | 1.4 | 1.7 | 2.2 | · | |
| P / Cash Flow | -10.1 | -72.2 | -9.8 | -12.8 | -47.9 | · | |
| P / FCF | -10.0 | -71.6 | -9.5 | -11.1 | -44.1 | · | |
| Earnings Yield | -13.3% | -2.4% | -12.3% | -11.5% | -7.0% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $4M | $0 | $10M | $0 | $0 | $0 | $439.0K | $9M | $1M | $3M | $1M | $2M | $2M | $2M | $2M | |
| R&D Expense | $31M | $27M | $32M | $35M | $35M | $25M | $21M | $19M | $15M | $14M | $12M | $15M | $16M | $14M | $14M | $10M | |
| SG&A Expense | $11M | $11M | $11M | $11M | $10M | $10M | $8M | $18M | $8M | $7M | $6M | $7M | $6M | $6M | $6M | $5M | |
| Operating Income | $-32M | $-34M | $-42M | $-35M | $-45M | $-35M | $-29M | $-36M | $-14M | $-20M | $-16M | $-21M | $-20M | $-18M | $-17M | $-14M | |
| Other Non-op | $10M | $10M | $10M | $11M | $11M | $11M | $9M | $8M | $8M | $5M | $4M | $3M | $3M | $1M | $373.0K | $132.0K | |
| Net Income | $-22M | $-24M | $-32M | $-24M | $-34M | $-24M | $-20M | $-28M | $-6M | $-15M | $-12M | $-18M | $-17M | $-17M | $-17M | $-13M | |
| EPS (Basic) | $-0.35 | $-0.39 | $-0.51 | $-0.39 | $-0.55 | $-0.38 | $-0.36 | $-0.51 | $-0.11 | $-0.30 | $-0.25 | $-0.42 | $-0.42 | $-0.40 | $-0.41 | $-0.32 | |
| EPS (Diluted) | $-0.35 | $-0.39 | $-0.51 | $-0.39 | $-0.55 | $-0.38 | $-0.36 | $-0.51 | $-0.11 | $-0.30 | $-0.25 | $-0.42 | $-0.42 | $-0.40 | $-0.41 | $-0.32 | |
| Shares (Basic) | 62,937,295 | 62,665,717 | · | 62,023,685 | 61,902,411 | 61,791,721 | · | 54,628,670 | 54,451,666 | 49,049,741 | 45,708,649 | 41,836,238 | 41,763,971 | 41,526,524 | 41,448,743 | 41,315,482 | |
| Shares (Diluted) | 62,937,295 | 62,665,717 | · | 62,023,685 | 61,902,411 | 61,791,721 | · | 54,628,670 | 54,451,666 | 49,049,741 | 45,708,649 | 41,836,238 | 41,763,971 | 41,526,524 | 41,448,743 | 41,315,482 | |
| EBITDA | $-32M | $-34M | · | $-35M | $-45M | $-35M | · | $-36M | $-14M | $-20M | $-16M | $-21M | $-20M | $-18M | $-17M | $-14M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $52M | $52M | $48M | $52M | $74M | $431M | $27M | $15M | $213M | $17M | $34M | $30M | $65M | $58M | $55M | |
| Short-term Investments | $943M | $905M | $914M | $941M | $944M | $940M | $595M | $631M | $632M | $439M | $333M | $270M | $287M | $274M | $296M | $306M | |
| Receivables | $149.0K | $35M | · | · | · | · | · | · | $8M | $519.0K | $0 | $0 | $750.0K | $500.0K | $0 | $0 | |
| Prepaid Expense | $12M | $11M | $9M | $9M | $10M | $9M | $8M | $8M | $8M | $6M | $5M | $6M | $4M | $5M | $4M | $3M | |
| Current Assets | $983M | $1.00B | $976M | $998M | $1.01B | $1.02B | $1.03B | $666M | $662M | $659M | $355M | $309M | $321M | $344M | $358M | $365M | |
| PP&E (Net) | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $7M | $7M | $7M | $7M | $7M | $4M | $3M | |
| PP&E (Gross) | $11M | $11M | $11M | $11M | $11M | $10M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $7M | $4M | $3M | |
| Accum. Depreciation | $8M | $7M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $1M | $567.0K | $320.0K | $212.0K | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $207.0K | $337.0K | |
| Total Assets | $1.01B | $1.03B | $1.00B | $1.02B | $1.03B | $1.05B | $1.06B | $695M | $691M | $689M | $387M | $342M | $353M | $376M | $385M | $369M | |
| Accounts Payable | $3M | $3M | $5M | $3M | $3M | $2M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $2M | |
| Accrued Liabilities | $20M | $15M | $18M | $22M | $16M | $13M | $12M | $13M | $9M | $6M | $7M | $9M | $8M | $7M | $4M | $5M | |
| Current Liabilities | $60M | $59M | $25M | $28M | $21M | $18M | $17M | $17M | $12M | $11M | $14M | $18M | $16M | $16M | $13M | $13M | |
| Capital Leases | $18M | $19M | $20M | $20M | $20M | $21M | $21M | $22M | $22M | $23M | $23M | $24M | $24M | $24M | $23M | $0 | |
| Total Liabilities | $80M | $87M | $45M | $48M | $42M | $38M | $39M | $39M | $34M | $33M | $38M | $42M | $42M | $44M | $42M | $13M | |
| Common Stock | $61.0K | $60.0K | $60.0K | $60.0K | $59.0K | $59.0K | $59.0K | $52.0K | $52.0K | $51.0K | $46.0K | $42.0K | $42.0K | $42.0K | $42.0K | $41.0K | |
| Retained Earnings | $-398M | $-376M | $-351M | $-319M | $-295M | $-261M | $-238M | $-218M | $-189M | $-184M | $-157M | $-145M | $-128M | $-94M | $-78M | $-61M | |
| AOCI | $-2M | $576.0K | $4M | $5M | $4M | $4M | $2M | $8M | $-2M | $-524.0K | $-1M | $-1M | $-739.0K | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $928M | $942M | $957M | $977M | $991M | $1.01B | $1.02B | $656M | $658M | $656M | $349M | $299M | $311M | $332M | $344M | $356M | |
| Liabilities + Equity | $1.01B | $1.03B | $1.00B | $1.02B | $1.03B | $1.05B | $1.06B | $695M | $691M | $689M | $387M | $342M | $353M | $376M | $385M | $369M | |
| Shares Outstanding | 61,077,980 | 60,865,458 | 60,384,283 | 60,123,602 | 59,297,814 | 59,168,490 | 59,064,606 | 52,337,239 | 52,162,215 | 51,840,571 | 46,151,427 | 41,867,536 | 41,802,807 | 41,550,704 | 41,501,269 | 41,393,660 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $10M | $9M | $11M | $11M | $6M | $15M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | |
| Operating Cash Flow | $12M | $-12M | $-29M | $-13M | $-24M | $-17M | $-17M | $-2M | $-10M | $-15M | $-12M | $-15M | $-14M | $-13M | $-6M | $-12M | |
| CapEx | $202.0K | $273.0K | $106.0K | $93.0K | $473.0K | $371.0K | $42.0K | $25.0K | $95.0K | $197.0K | $470.0K | $580.0K | $285.0K | $3M | $898.0K | $971.0K | |
| Investing Cash Flow | $-39M | $8M | $30M | $8M | $2M | $-340M | $34M | $13M | $-191M | $-114M | $-61M | $18M | $-9M | $20M | $9M | $31M | |
| Financing Cash Flow | $2M | $4M | $3M | $493.0K | $954.0K | $554.0K | $387M | $2M | $3M | $322M | $57M | $528.0K | $2M | $0 | $308.0K | $1.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-17M | · | · | · | $-15M | · | · | $-14M | · | · | $-12M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -308.7% | -916.5% | · | -352.5% | · | · | · | -8164.5% | -155.4% | -1610.3% | -628.2% | -1962.9% | -990.3% | -994.0% | -729.9% | -852.2% | |
| Net Margin | -214.0% | -652.6% | · | -243.1% | · | · | · | -6391.6% | -67.0% | -1178.9% | -459.6% | -1656.4% | -852.5% | -920.9% | -714.1% | -843.9% | |
| EBITDA Margin | -308.7% | -916.5% | · | -352.5% | · | · | · | -8164.5% | -155.4% | -1610.3% | -628.2% | -1962.9% | -990.3% | -994.0% | -729.9% | -852.2% | |
| ROA | -2.1% | -2.3% | · | -2.8% | -3.9% | -2.7% | · | -5.2% | -1.1% | -2.8% | -3.0% | -4.8% | -4.8% | -4.3% | -4.3% | -7.3% | |
| ROE | -2.3% | -2.5% | · | -3.0% | -4.1% | -2.8% | · | -5.6% | -1.2% | -3.0% | -3.4% | -5.4% | -5.2% | -4.7% | -4.6% | -7.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.3 | 17.0 | · | 35.9 | 47.0 | 58.5 | · | 38.8 | 57.3 | 62.1 | 24.5 | 17.3 | 19.9 | 21.1 | 27.6 | 29.1 | |
| Quick Ratio | 16.1 | 16.8 | · | 35.5 | 46.6 | 57.9 | · | 38.3 | 56.6 | 61.5 | 24.2 | 16.9 | 19.7 | 20.8 | 27.3 | 28.9 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 2.7 | 0.2 | · | · | · | · | · | · | 2.4 | 2.0 | 10.1 | · | 5.5 | 7.3 | 12.6 | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.19 | $15.47 | · | $16.24 | $16.70 | $17.11 | · | $12.54 | $12.61 | $12.65 | $7.56 | $7.15 | $7.45 | $7.98 | $8.28 | $8.60 | |
| Revenue / Share | $0.16 | $0.06 | · | $0.16 | $0.00 | $0.00 | · | $0.01 | $0.16 | $0.03 | $0.06 | $0.03 | $0.05 | $0.04 | $0.06 | · | |
| Cash Flow / Share | · | $-0.20 | · | · | · | $-0.28 | · | · | · | $-0.30 | · | · | $-0.33 | · | · | · | |
| Cash / Share | $0.45 | $0.85 | · | $0.80 | $0.88 | $1.25 | · | $0.51 | $0.28 | $4.11 | $0.37 | $0.81 | $0.73 | $1.56 | $1.41 | $1.33 | |
| EPS (TTM) | $-1.64 | $-1.84 | · | $-1.68 | $-1.80 | $-1.36 | · | $-1.15 | $-0.89 | $-1.20 | $-1.48 | $-1.63 | $-1.62 | $-1.42 | $-1.28 | $-1.49 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24M | $14M | · | $10M | $439.0K | $9M | · | $13M | $15M | $7M | $8M | $8M | $9M | $7M | $7M | $5M | |
| Net Income TTM | $-103M | $-114M | · | $-102M | $-106M | $-78M | · | $-61M | $-44M | $-56M | $-63M | $-68M | $-67M | $-60M | $-54M | $-44M | |
| Market Cap | $938M | $846M | · | $1.47B | $1.37B | $1.60B | · | $2.38B | $2.19B | $1.95B | $465M | $497M | $506M | $563M | $507M | $594M | |
| P/E | -9.4 | -7.6 | · | -14.5 | -12.8 | -19.9 | · | -39.5 | -47.1 | -31.4 | -6.8 | -7.3 | -7.5 | -9.5 | -9.5 | -9.6 | |
| P/S | 39.1 | 61.6 | · | 146.9 | 3120.2 | 171.1 | · | 182.2 | 144.4 | 267.8 | 54.9 | 64.0 | 55.8 | 76.2 | 75.3 | 122.5 | |
| P/B | 1.0 | 0.9 | · | 1.5 | 1.4 | 1.6 | · | 3.6 | 3.3 | 3.0 | 1.3 | 1.7 | 1.6 | 1.7 | 1.5 | 1.7 | |
| P / Tangible Book | 1.0 | 0.9 | · | 1.5 | 1.4 | 1.6 | · | 3.6 | 3.3 | 3.0 | 1.3 | 1.7 | 1.6 | 1.7 | 1.5 | 1.7 | |
| P / Cash Flow | · | -68.6 | · | · | · | -93.8 | · | · | · | -131.5 | · | · | -36.4 | · | · | -51.5 | |
| Earnings Yield | -10.7% | -13.2% | · | -6.9% | -7.8% | -5.0% | · | -2.5% | -2.1% | -3.2% | -14.7% | -13.7% | -13.4% | -10.5% | -10.5% | -10.4% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $10M | $11M | $8M | $9M | $4M |
| Margen Operativo % | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% |
| Beneficio neto | $-114M | $-69M | $-58M | $-63M | $-33M |
| EPS Diluido | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 39.0 | 59.2 | 26.8 | 20.1 | 29.5 |
| Ratio Rápido | 38.7 | 58.7 | 26.4 | 19.8 | 29.3 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-83M | $-44M | $-52M | $-49M | $-18M |
Propietarios institucionales (13F) 216 declarantes · $1.0B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
216
Valor en tenencia
$1.0B
Nuevas posiciones
40
Posiciones cerradas
29
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 40 (-8 vs trimestre anterior) | 29 (+1 vs trimestre anterior) | 81 (+12 vs trimestre anterior) | 49 (-5 vs trimestre anterior) | +700K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $171 873 684 | 11 189 693 | 16,64% | Acciones |
| BlackRock, Inc. | $94 228 481 | 6 134 667 | 9,12% | Acciones |
| Prosight Management, LP | $58 436 828 | 3 804 481 | 5,66% | Acciones |
| JANUS HENDERSON GROUP PLC | $58 279 971 | 4 196 409 | 5,64% | Acciones |
| STATE STREET CORP | $46 155 249 | 3 004 899 | 4,47% | Acciones |
| VANGUARD GROUP INC | $40 108 126 | 2 906 386 | 3,88% | Acciones |
| FMR LLC | $37 060 986 | 2 412 825 | 3,59% | Acciones |
| FEDERATED HERMES, INC. | $36 140 959 | 2 352 927 | 3,50% | Acciones |
| Point72 Asset Management, L.P. | $30 625 336 | 1 993 837 | 2,97% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $28 528 911 | 1 857 351 | 2,76% | Acciones |
| TCG Crossover Management, LLC | $27 488 517 | 1 789 617 | 2,66% | Acciones |
| Alyeska Investment Group, L.P. | $25 300 070 | 1 647 140 | 2,45% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $23 153 049 | 1 507 360 | 2,24% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20 439 706 | 1 330 710 | 1,98% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $18 543 360 | 1 207 250 | 1,80% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $18 499 798 | 1 204 150 | 1,79% | Acciones |
| CITADEL ADVISORS LLC | $18 443 321 | 1 200 737 | 1,79% | Acciones |
| ALGERT GLOBAL LLC | $17 063 255 | 1 110 889 | 1,65% | Acciones |
| D. E. Shaw & Co., Inc. | $16 842 378 | 1 096 509 | 1,63% | Acciones |
| GOLDMAN SACHS GROUP INC | $14 633 088 | 952 675 | 1,42% | Acciones |
| BANK OF AMERICA CORP /DE/ | $13 984 665 | 910 460 | 1,35% | Acciones |
| MORGAN STANLEY | $12 855 801 | 836 966 | 1,24% | Acciones |
| Nantahala Capital Management, LLC | $12 440 279 | 809 914 | 1,20% | Acciones |
| Qube Research & Technologies Ltd | $10 783 596 | 702 057 | 1,04% | Acciones |
| Squarepoint Ops LLC | $8 176 451 | 532 321 | 0,79% | Acciones |
| ORBIMED ADVISORS LLC | $8 059 392 | 524 700 | 0,78% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $7 749 796 | 504 544 | 0,75% | Acciones |
| ADAR1 Capital Management, LLC | $6 464 732 | 420 881 | 0,63% | Acciones |
| Cubist Systematic Strategies, LLC | $6 293 960 | 257 527 | 0,61% | Acciones |
| NORTHERN TRUST CORP | $6 118 902 | 398 366 | 0,59% | Acciones |
| JANE STREET GROUP, LLC | $6 020 981 | 391 991 | 0,58% | Acciones |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $5 782 979 | 376 496 | 0,56% | Acciones |
| Woodline Partners LP | $5 683 692 | 370 032 | 0,55% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5 670 774 | 369 191 | 0,55% | Acciones |
| Rock Springs Capital Management LP | $5 637 258 | 367 009 | 0,55% | Acciones |
| Jump Financial, LLC | $5 555 174 | 361 665 | 0,54% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $5 525 376 | 359 725 | 0,54% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $4 842 563 | 315 271 | 0,47% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $4 133 576 | 269 113 | 0,40% | Acciones |
| Man Group plc | $3 821 583 | 248 801 | 0,37% | Acciones |
| Balyasny Asset Management L.P. | $3 250 714 | 211 635 | 0,31% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $3 219 348 | 209 593 | 0,31% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $3 018 040 | 196 487 | 0,29% | Acciones |
| JPMORGAN CHASE & CO | $2 736 049 | 178 535 | 0,26% | Acciones |
| Allspring Global Investments Holdings, LLC | $2 434 909 | 166 092 | 0,24% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 403 840 | 156 500 | 0,23% | Opción de venta |
| BML Capital Management, LLC | $2 380 201 | 154 961 | 0,23% | Acciones |
| UBS Group AG | $2 314 767 | 150 701 | 0,22% | Acciones |
| Springhill Fund Asset Management (HK) Co Ltd | $2 119 500 | 78 500 | 0,21% | Acciones |
| Bank of New York Mellon Corp | $2 074 706 | 135 072 | 0,20% | Acciones |
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 presentaciones | 10 de marzo de 2025 | 19,90% | Enmienda | · | SEC |
| Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P., Avalon BioVentures I, LP, Avalon Ventures XI GP LLC, ABV SPV I GP LLC, Avalon BioVentures GP, LLC, Kevin Kinsella, Richard Levandov, Braden Bohrmann, Jay Lichter, Ph.D., Tighe Reardon, Sergio G. Duron, Ph.D., Sanford Madigan, Ph.D. ×6 presentaciones | 8 de noviembre de 2024 | · | Presentación inicial | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×3 presentaciones | 9 de agosto de 2024 | · | Presentación inicial | · | SEC |
| Avalon Ventures XI, L.P. (“Avalon Ventures”), Avalon BioVentures SPV I, L.P. (“ABV SPV”), Avalon Bioventures I, LP (“ABV I”), Avalon Ventures XI GP LLC (“Avalon XI GP”), ABV SPV I GP LLC (“ABV SPV GP”), Avalon BioVentures GP, LLC (“ABV GP”), Kevin Kinsella (“Kinsella”), Richard Levandov (“Levandov”), Braden Bohrmann (“Bohrmann”), Jay Lichter, Ph.D. (“Lichter”), Tighe Reardon (“Reardon”), Sergio Duron (“Duron”), Sanford Madigan, Ph.D. (“Madigan”) ×2 presentaciones | 16 de noviembre de 2023 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 24 insiders · 12 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| David Alan Campbell | President and CEO | 31 de julio de 2026 G | 264 742 | 0 | 1 | $-110 829 |
| Tighe Reardon | Acting Chief Financial Officer | 3 de junio de 2024 S | 3 340 018 | 0 | 0 | $0 |
| Janeen Noel Doyle | Chief Corp. & Bus. Dev. Ofcr | 2 de junio de 2026 S | 75 941 | 0 | 1 | $-56 948 |
| Maria Dobek | Vice President, Accounting | 11 de mayo de 2026 S | 32 270 | 0 | 2 | $-48 951 |
| William Go | Chief Medical Officer | 2 de febrero de 2026 A | 44 000 | 0 | 0 | $0 |
| Zachariah Mciver | Chief Medical Officer | 2 de enero de 2026 A | 52 286 | 0 | 1 | $-37 263 |
| Thomas Diraimondo | Chief Scientific Officer | 2 de enero de 2026 A | 155 825 | 0 | 1 | $-34 394 |
| Charles M. Winter | Chief Technical Officer | 2 de enero de 2026 A | 106 321 | 0 | 1 | $-32 966 |
| Andrew Hollman Meyer | Chief Business Officer | 2 de enero de 2026 S | 83 095 | 0 | 5 | $-736 652 |
| Byron Robinson | Chief Strategy Officer | 2 de enero de 2025 A | 28 000 | 0 | 0 | $0 |
| Wayne Godfrey | Chief Medical Officer | 3 de enero de 2023 A | · | 0 | 0 | $0 |
| Shahram Salek-Ardakani | Chief Scientific Officer | 3 de enero de 2022 A | · | 0 | 0 | $0 |
| Jake Simson | Consejero | 11 de junio de 2026 A | 11 750 | 0 | 0 | $0 |
| Natasha Hernday | Consejero | 11 de junio de 2026 A | 15 481 | 0 | 0 | $0 |
| Winston Kung | Consejero | 11 de junio de 2026 A | 11 750 | 0 | 0 | $0 |
| Ronald W Barrett | Consejero | 11 de junio de 2026 A | 11 750 | 0 | 0 | $0 |
| Vickie L Capps | Consejero | 11 de junio de 2026 A | 79 598 | 0 | 0 | $0 |
| Eric Dobmeier | Consejero | 11 de junio de 2026 A | 15 481 | 0 | 0 | $0 |
| Alana B. Mcnulty | Consejero | 11 de junio de 2025 A | 6 250 | 0 | 0 | $0 |
| Sheila Gujrathi | Consejero | 11 de junio de 2025 A | 118 889 | 0 | 0 | $0 |
| Stefan Heller | Consejero | 14 de junio de 2022 A | · | 0 | 0 | $0 |
| Peter A. Thompson | Consejero | 14 de junio de 2022 A | 231 098 | 0 | 0 | $0 |
| Jay Lichter | Propietario del 10% | 13 de septiembre de 2024 M | 7 000 | 0 | 0 | $0 |
| Bregua Corp | Propietario del 10% | 15 de junio de 2021 C | 3 749 250 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 29 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IDNA · iShares Trust | 0,98% | 142 050 SH | 11 de septiembre de 2026 | Diario |
| BBC · ETFis Series Trust I | 0,75% | 22 923 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,20% | 65 529 NS | 31 de julio de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,12% | 2 826 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,07% | 435 895 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 4 350 SH | 1 de octubre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,06% | 895 NS | 31 de julio de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 37 644 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 48 130 SH | 1 de octubre de 2026 | Diario |
| FBCG · FIDELITY COVINGTON TRUST | 0,03% | 123 298 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1 107 172 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,02% | 20 662 NS | 31 de julio de 2026 | N-PORT |
| TECB · iShares Trust | 0,02% | 5 624 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 248 060 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,01% | 123 038 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 552 164 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 117 899 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 18 188 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2 569 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,00% | 5 688 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1 318 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 68 785 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 13 661 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 263 837 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 110 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 402 945 SH | 11 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 2 013 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 9 972 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 53 769 SH | 11 de septiembre de 2026 | Diario |
JANX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 26 analistas
COMPRA
Objetivo mediano
$29.00
+71,3%
10 38,5%
Compra fuerte
12 46,2%
Compra
3 11,5%
Mantener
1 3,8%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
17 analistas · 2026-09-28Objetivo medio $36.24 +114,0%
Ahora
Precio Actual $16.93
Mín$14.00
Media$36.24
Máx$75.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | · |
| BCAX | $953M | -6.7 | · | · | -33.0% | · |
| TRAX | · | · | · | · | · | · |
| VOR | $506M | -0.2 | · | · | 83.4% | · |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | · |
| AKTS | · | · | · | · | · | · |
| ODTX | · | · | · | · | · | · |
| SVRA | $1.23B | -11.4 | · | · | -73.4% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| CGEM | $624M | -3.2 | · | · | -44.0% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026